GB1305502A - - Google Patents

Info

Publication number
GB1305502A
GB1305502A GB1252771A GB1252771A GB1305502A GB 1305502 A GB1305502 A GB 1305502A GB 1252771 A GB1252771 A GB 1252771A GB 1252771 A GB1252771 A GB 1252771A GB 1305502 A GB1305502 A GB 1305502A
Authority
GB
United Kingdom
Prior art keywords
alkyl
hydrogen
formula
aldehyde
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1252771A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1305502A publication Critical patent/GB1305502A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/04Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
GB1252771A 1970-12-16 1971-04-30 Expired GB1305502A (enrdf_load_stackoverflow)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9886070A 1970-12-16 1970-12-16

Publications (1)

Publication Number Publication Date
GB1305502A true GB1305502A (enrdf_load_stackoverflow) 1973-02-07

Family

ID=22271290

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1252771A Expired GB1305502A (enrdf_load_stackoverflow) 1970-12-16 1971-04-30

Country Status (2)

Country Link
US (1) US3729564A (enrdf_load_stackoverflow)
GB (1) GB1305502A (enrdf_load_stackoverflow)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4033748A (en) 1976-07-02 1977-07-05 Merck & Co., Inc. Dibicyclo[3.1.1] and [2.2.1] heptyl and dibicyclo [3.1.1] and [2.2.1] heptenyl polyamines having a piperidine moiety
US4049559A (en) 1975-10-09 1977-09-20 Merck & Co., Inc. Composition for secondary and tertiary oil recovery
US4100193A (en) * 1976-06-10 1978-07-11 Merck & Co., Inc. Novel dibicyclo [2.2.2] octyl and dibicyclo [2.2.2] octenyl polyamines and methods for their preparation
GB2153831A (en) * 1984-01-14 1985-08-29 Claude Hepburn The use of cationic surfactants as crosslinking agents
WO1994025426A1 (en) * 1993-04-28 1994-11-10 Alcon Laboratories, Inc. Diamines as antimicrobial agents and use thereof in ophthalmic composition

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049417A (en) * 1975-04-28 1977-09-20 Merck & Co., Inc. Alicyclic alkylene polyamine microorganism and algae growth inhibitors
US7445771B2 (en) * 2003-12-09 2008-11-04 Alcon, Inc. Use of bis-amines to enhance the antimicrobial activity of aqueous compositions
CA3165769A1 (en) 2011-12-07 2013-06-13 Alnylam Pharmaceuticals, Inc. Biodegradable lipids for the delivery of active agents
EP4148083A1 (en) 2014-06-25 2023-03-15 Acuitas Therapeutics Inc. Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
US10221127B2 (en) 2015-06-29 2019-03-05 Acuitas Therapeutics, Inc. Lipids and lipid nanoparticle formulations for delivery of nucleic acids
WO2017075531A1 (en) 2015-10-28 2017-05-04 Acuitas Therapeutics, Inc. Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
US11357856B2 (en) 2017-04-13 2022-06-14 Acuitas Therapeutics, Inc. Lipids for delivery of active agents
IL301115A (en) 2017-04-28 2023-05-01 Acuitas Therapeutics Inc Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
WO2019036008A1 (en) 2017-08-16 2019-02-21 Acuitas Therapeutics, Inc. LIPIDS FOR USE IN LIPID NANOPARTICULAR FORMULATIONS
US11542225B2 (en) 2017-08-17 2023-01-03 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
EP3668834B1 (en) 2017-08-17 2024-10-02 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations
WO2019036030A1 (en) 2017-08-17 2019-02-21 Acuitas Therapeutics, Inc. LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS
EP3728181B1 (en) * 2017-12-20 2024-05-08 Specialty Operations France New cationic quaternary ammonium compounds and compositions comprising same and processes for their manufacture
IL322436A (en) 2018-09-21 2025-09-01 Acuitas Therapeutics Inc Systems and methods for producing lipid nanoparticles and liposomes
US11453639B2 (en) 2019-01-11 2022-09-27 Acuitas Therapeutics, Inc. Lipids for lipid nanoparticle delivery of active agents
IL299787A (en) 2020-07-16 2023-03-01 Acuitas Therapeutics Inc Cationic lipids for use in lipid nanoparticles
US12129223B2 (en) 2021-12-16 2024-10-29 Acuitas Therapeutics, Inc. Lipids for use in lipid nanoparticle formulations

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049559A (en) 1975-10-09 1977-09-20 Merck & Co., Inc. Composition for secondary and tertiary oil recovery
US4100193A (en) * 1976-06-10 1978-07-11 Merck & Co., Inc. Novel dibicyclo [2.2.2] octyl and dibicyclo [2.2.2] octenyl polyamines and methods for their preparation
US4033748A (en) 1976-07-02 1977-07-05 Merck & Co., Inc. Dibicyclo[3.1.1] and [2.2.1] heptyl and dibicyclo [3.1.1] and [2.2.1] heptenyl polyamines having a piperidine moiety
GB2153831A (en) * 1984-01-14 1985-08-29 Claude Hepburn The use of cationic surfactants as crosslinking agents
WO1994025426A1 (en) * 1993-04-28 1994-11-10 Alcon Laboratories, Inc. Diamines as antimicrobial agents and use thereof in ophthalmic composition
US5900213A (en) * 1993-04-28 1999-05-04 Alcon Laboratories, Inc. Use of diamines to disinfect and clean contact lenses and preserve ophthalmic compositions

Also Published As

Publication number Publication date
US3729564A (en) 1973-04-24

Similar Documents

Publication Publication Date Title
GB1305502A (enrdf_load_stackoverflow)
ES403503A1 (es) Procedimiento para la preparación de derivados de piperidina y su utilizacion como estabilizadores
GB1395802A (en) Substituted benzamides and herbicidal uses thereof
ES457993A1 (es) Un procedimiento para la preparacion de una isotiazolopiri- dina.
GB1059995A (en) Preparation of alkyl 3-chloro-3-arylimino-propionates and tautomers thereof
ES409192A1 (es) Procedimiento para la preparacion de derivados del acido amino-citrico.
GB1343163A (en) Cyclopropane carboxylates processes for producing them and compo sitions containing them
GB1208195A (en) Process for producing benzodiazepine derivatives
GB1329680A (en) Process for the preparation of carbanilic acid propargyl esters
GB1359171A (en) Azo dye-stuffs their manufacture and use
ES394727A1 (es) Procedimiento para la obtencion de nuevos derivados de la tiazolino-pirimidona-5.
ES393107A1 (es) Procedimiento para la preparacion de cianuros de diazonio.
ES419739A1 (es) Procedimiento para la preparacion de 2-arilamino-imidazoli-nas (2) sustituidas.
GB1237658A (en) Substituted 1-oxy-1-thiono-3-halogen- or -3-alkyl phospholines
ES303109A1 (es) Procedimiento para la preparacion de imidazo quinazolinas y pirimido quinazolinas.
GB1193347A (en) Production of Alkylenealdehyde-Substituted Hexahydropyrimidin-2-Ones and -Thiones
GB1454529A (en) Thiophene derivatives
ES402551A1 (es) Un procedimiento para la preparacion de derivados de pipe- razina.
ES419656A1 (es) Un procedimiento para la produccion de un compuesto de un ester alilaminoalcanolico.
ES320141A1 (es) Un procedimiento para la preparacion de penicilinas.
ES387817A1 (es) Procedimiento de obtencion de composiciones insecticidas y fungicidas a base de esteres organicos del acido fosfori- co.
ES393339A1 (es) Un procedimiento para la preparacion de derivados de nafto-quinona.
GB1499193A (en) Indolino-spiropyran compounds useful as colour formers
ES417729A1 (es) Procedimiento para la preparacion de nuevos aminoetanoles.
ES356224A1 (es) Procedimiento para la produccion de diariletilaminas.

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee